Navigation Links
22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire/ -- 22nd Century Group, Inc. (OTCBB: XXII) today announced that Joseph Pandolfino, Chief Executive Officer, and Henry Sicignano III, President, will present at RetailInvestorConferences.com.

DATE:

December 5, 2013

TIME:   

1:15 PM EST

LINK:  

www.retailinvestorconferences.com click on the red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

The Retail Investor Conferences event is part of the Virtual Investor Conference Series co-hosted by MUNCmedia, Better Investing (NAIC) and PR Newswire.  Individual investors, institutional investors, financial advisors and financial analysts are invited to attend.  

It is recommended that investors pre-register to save time and receive event updates.

About 22nd Century Group:

22nd Century Group, Inc. (OTCBB: XXII) is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. 22nd Century owns or is the exclusive licensee of 114 issued patents in 78 countries plus an additional 36 pending patent applications. Goodrich Tobacco Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century. Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. www.xxiicentury.com

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com is the world's largest monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites leading-edge online conferencing by PR Newswire with the investor communications capabilities of MUNCmedia's digital public relations, content marketing and audience development services and BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE 22nd Century Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
2. KaloBios to Present at BioCenturys NewsMakers in the Biotech Industry Conference
3. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
4. MEI Pharma to Present at BioCenturys NewsMakers in the Biotech Industry Conference
5. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
6. Dalia Dergham Joins Grace Century FZ LLC International Project Team
7. Grace Century Attends Provia Laboratories Cycle II Launch
8. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
11. Stanford scientists spark new interest in the century-old Edison battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... , ... July 26, 2017 , ... Vincent R. Burton, ... which is licensed by the Bahamas’ National Stem Cell Ethics Committee (NSCEC). , ... University of the West Indies. He went on to complete residency training in the ...
(Date:7/26/2017)... July 26th, 2017 /PRNewswire/ - Caprion Biosciences Inc., a world leading ... host blood proteins predictive of early stage (latent) Mycobacterium tuberculosis ... multiple reaction monitoring (MRM-MS) platform. ... Caprion Biosciences Inc. (CNW ... The new data, ...
(Date:7/26/2017)... ... July 25, 2017 , ... The leading Regenerative Veterinary Medicine ... cell therapy has been used on more than 13,000 animals. VetStem was ... fatal injuries to tendons and ligaments. , In 2003 VetStem signed a worldwide ...
(Date:7/26/2017)... ... 26, 2017 , ... Spectral imaging is a non-destructive technique ... This unique capability combines high resolution imaging with spectral analysis. The system ... for chemical analysis, quality control, and decision-making. , Snapshot spectral imaging is key ...
Breaking Biology Technology:
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):